Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$1.3 million.

  • Quipt Home Medical's Change in Inventory fell 26310.43% to -$1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $349000.0, marking a year-over-year decrease of 8798.21%. This contributed to the annual value of $2.4 million for FY2025, which is 2932.75% down from last year.
  • Latest data reveals that Quipt Home Medical reported Change in Inventory of -$1.3 million as of Q4 2025, which was down 26310.43% from -$726000.0 recorded in Q3 2025.
  • Quipt Home Medical's 5-year Change in Inventory high stood at $2.7 million for Q1 2024, and its period low was -$1.7 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Inventory was $29500.0 (2021), whereas its average is $179300.0.
  • In the last 5 years, Quipt Home Medical's Change in Inventory crashed by 12840000.0% in 2022 and then skyrocketed by 65354.84% in 2025.
  • Quarter analysis of 5 years shows Quipt Home Medical's Change in Inventory stood at $1000.0 in 2021, then crashed by 128400.0% to -$1.3 million in 2022, then skyrocketed by 201.48% to $1.3 million in 2023, then tumbled by 39.63% to $786000.0 in 2024, then tumbled by 263.1% to -$1.3 million in 2025.
  • Its Change in Inventory stands at -$1.3 million for Q4 2025, versus -$726000.0 for Q3 2025 and $1.2 million for Q2 2025.